Kirkwood Carl D, Roczo Susie, Boniface Karen, Bishop Ruth F, Barnes Graeme L
Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria.
Commun Dis Intell Q Rep. 2011 Dec;35(4):281-7.
The Australian Rotavirus Surveillance Program together with collaborating laboratories Australia-wide conducts a laboratory based rotavirus surveillance program. This report describes the genotypes of rotavirus strains responsible for the hospitalisation of children with acute gastroenteritis during 1 July 2010 to 30 June 2011. This report represents the fourth year of surveillance following introduction of rotavirus vaccines into the National Immunisation Program. One thousand one hundred and twenty-seven faecal samples were referred to the centre for G and P genotype analysis using hemi-nested multiplex reverse transcription-polymerase chain reaction. Eight hundred and sixteen samples were confirmed as rotavirus positive. Of these, 551 were collected from children under 5 years of age, while 265 were from older children and adults. Genotype analysis revealed that a change in the dominant type occurred in this reporting period, such that genotype G2P[4] was the dominant type nationally, representing 51% of samples, followed by genotype G1P[8] (26.1%). Genotypes G3P[8] represented 11% of samples while G4P[8] re-emerged as an important genotype, and was identified in 6% of samples. Uncommon rotavirus G and P combinations continue to be identified, with G2P[8] and G9P[4] identified during this survey. Differences in genotype distribution based on vaccine usage continue to be evident in Australian states. This survey continues to highlight the fluctuations in rotavirus genotypes, with an annual change in dominant genotypes suggesting a more dynamic wild-type population.
澳大利亚轮状病毒监测项目与全澳的合作实验室共同开展了一项基于实验室的轮状病毒监测项目。本报告描述了2010年7月1日至2011年6月30日期间导致急性肠胃炎患儿住院的轮状病毒株的基因型。本报告是轮状病毒疫苗被纳入国家免疫规划后的第四年监测报告。1127份粪便样本被送往该中心,使用半巢式多重逆转录-聚合酶链反应进行G和P基因型分析。816份样本被确认为轮状病毒阳性。其中,551份样本采集自5岁以下儿童,265份样本来自年龄较大的儿童和成人。基因型分析显示,在本报告期内优势类型发生了变化,基因型G2P[4]在全国范围内成为优势类型,占样本的51%,其次是基因型G1P[8](26.1%)。基因型G3P[8]占样本的11%,而G4P[8]重新成为一种重要的基因型,在6%的样本中被鉴定出来。罕见的轮状病毒G和P组合仍在不断被发现,本次调查中鉴定出了G2P[8]和G9P[4]。基于疫苗使用情况的基因型分布差异在澳大利亚各州仍然很明显。本次调查继续凸显了轮状病毒基因型的波动,优势基因型的年度变化表明野生型群体更加动态多变。